ReGelTec
Baltimore, US · Founded 2018 · 2 known investors
Find your way into ReGelTec
275 people in our graph share verified history with the ReGelTec team — schools, employers, funds. One of them is your warm intro.
Rob Ludwigunlockedknows Peter Boyd · together at University of Virginia School of Law (overlapped)
knows the team · via University of Virginia School of Law
knows the team · via University of Virginia Darden School of Business
×9knows the team · via Latham & Watkins
ReGelTec develops injectable hydrogel technology for the repair of the nucleus pulposus of the intervertebral disc, targeting interventional pain management and spine care. The company is a medical device (MedTech) startup combining academic research in crosslinked polymers with experienced medical device executives.
Founders & leadership
ReGelTec was founded in 2018 by Bill Niland.
BN
Bill NilandinCo-Founder & AdvisorHe has prior experience as a Chief Executive Officer in the medical device industry, with expertise in business development, early-stage startups, and clinical trials.
PB
Peter BoydinCEOPeter Boyd is CEO of ReGelTec, a medical device company developing injectable hydrogel technology for intervertebral disc repair. He previously co-founded Harpoon Medical, which he helped scale to a $250M exit in less than five years, and holds a JD/MBA from UVA and California Bar membership.
AL
Anthony LowmaninCTO & Co-Founder
MC
Mark CollinsinCFO
MA
Moss AmerNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 of 3 rounds · 2018–2020
▶$4MraisedJan 2021 · 30 investors · BiotechnologyRule 506(b)
▶$4MraisedJan 2021 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony LowmanDirector
- William NilandExecutive Officer, Director
- Mark CollinsExecutive Officer
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2MraisedNov 2018 · 17 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2018 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Anthony LowmanDirector
- Mark CollinsExecutive Officer
- Moss AmerDirector
- William NilandExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does ReGelTec do?
- ReGelTec develops injectable hydrogel technology for the repair of the nucleus pulposus of the intervertebral disc, targeting interventional pain management and spine care. The company is a medical device (MedTech) startup combining academic research in crosslinked polymers with experienced medical device executives.
- Who founded ReGelTec?
- ReGelTec was founded by Bill Niland in 2018.
- Who are ReGelTec's investors?
- ReGelTec's investors include Riptide Ventures, Tech Council Ventures.
- How much funding has ReGelTec raised?
- ReGelTec has disclosed $6M raised across 2 of its 3 known rounds.
- Where is ReGelTec headquartered?
- ReGelTec is headquartered in Baltimore, US.